KATIE RIEGLE: Open Payments
NPI 1245509660 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 38 payments from 17 companies in 2025. Trend: 2023 $2,033 · 2024 $436 · 2025 $690
Food & beverage: $690
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $167 |
| PFIZER INC. | 6 | $99 |
| Astellas Pharma US Inc | 2 | $53 |
| Lilly USA, LLC | 3 | $52 |
| Amgen Inc. | 3 | $45 |
| Tempus AI, Inc | 1 | $39 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Edwards Lifesciences Corporation | 1 | $30 |
| Biosense Webster, Inc. | 1 | $26 |
| Radius Health, Inc. | 1 | $25 |
Products named: QULIPTA, NURTEC ODT, Veozah, MOUNJARO, VRAYLAR, EVENITY, XT CDX, ELIQUIS.
Industry payments across FL — which companies pay providers there.
